Title:
SUBSTITUTED HETEROCYCLES AS ANTIVIRAL AGENTS
Document Type and Number:
WIPO Patent Application WO/2019/143902
Kind Code:
A3
Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts thereof: which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Inventors:
PANARESE JOSEPH (US)
BARTLETT SAMUEL (US)
CHONG KATHERINE (US)
OR YAT SUN (US)
BARTLETT SAMUEL (US)
CHONG KATHERINE (US)
OR YAT SUN (US)
Application Number:
PCT/US2019/014144
Publication Date:
September 26, 2019
Filing Date:
January 18, 2019
Export Citation:
Assignee:
ENANTA PHARM INC (US)
International Classes:
A61K31/4745; A61K31/496; A61K31/5377; C07D455/06
Foreign References:
US20160296515A1 | 2016-10-13 | |||
US20170253609A1 | 2017-09-07 |
Attorney, Agent or Firm:
HARLAN, Edgar, W. (US)
Download PDF:
Previous Patent: DUAL ADVANCED AUDIO DISTRIBUTION PROFILE (A2DP) SINK
Next Patent: COLOR MIXING FROM DIFFERENT LIGHT SOURCES
Next Patent: COLOR MIXING FROM DIFFERENT LIGHT SOURCES